Becton Dickinson (BD) is a leading global medical technology company dedicated to enhancing human health through the development, design, and distribution of innovative medical equipment, instrument systems, and reagents. With a mission to improve healthcare outcomes worldwide, BD has established itself as a vital player in the medical industry.
Founded in 1897 and headquartered in Franklin Lakes, New Jersey, BD operates in over 50 countries, making its impact felt on a truly international scale. The company serves a diverse clientele that includes healthcare institutions, life sciences researchers, clinical laboratories, pharmaceutical companies, and the general public, providing essential products and solutions that support various facets of medical care and research.
BD's product portfolio is extensive, featuring advanced needle technologies, refillable syringes, and comprehensive safety and shielding systems. Among its notable innovations are cutting-edge needle technologies designed to optimize the needle point and cannula configuration, tailored specifically to meet diverse drug delivery requirements. Through continuous research and development, Becton Dickinson remains at the forefront of medical technology, committed to improving patient safety and outcomes globally.